Dark Forest Capital Management LP G1 Therapeutics, Inc. Transaction History

Dark Forest Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$2.57 - $8.16 $21,937 - $69,653	8,536 New	8,536 $22,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $2,595 - $8,528	502 New	502 $6,000
Q1 2022 May 13, 2022	SELL	$7.6 - $11.02 $3,640 - $5,278	-479 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$10.16 - $16.17 $4,297 - $6,839	423 Added 755.36%	479 $5,000
Q3 2021 Nov 12, 2021	SELL	$13.16 - $22.47 $8,106 - $13,841	-616 Reduced 91.67%	56 $1,000
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $13,151 - $17,687	672 New	672 $15,000

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.